Related references
Note: Only part of the references are listed.Expression and prognostic significance of fibronectin and matrix metalloproteases in breast cancer metastasis
Belen Fernandez-Garcia et al.
HISTOPATHOLOGY (2014)
Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer
Kamal S. Saini et al.
CANCER TREATMENT REVIEWS (2013)
Host pigment epithelium-derived factor (PEDF) prevents progression of liver metastasis in a mouse model of uveal melanoma
John M. Lattier et al.
CLINICAL & EXPERIMENTAL METASTASIS (2013)
Fibronectin expression in carcinoma cells correlates with tumor aggressiveness and poor clinical outcome in patients with invasive breast cancer
Young Kyung Bae et al.
HUMAN PATHOLOGY (2013)
Epigallocatechin-3-gallate potentiates curcumin's ability to suppress uterine leiomyosarcoma cell growth and induce apoptosis
Akiko Kondo et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2013)
The effects of PEDF on cancer biology: mechanisms of action and therapeutic potential
S. Patricia Becerra et al.
NATURE REVIEWS CANCER (2013)
Cross-talk between mitogenic Ras/MAPK and survival PI3K/Akt pathways: a fine balance
Edita Aksamitiene et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2012)
Opposing Effects of Pigment Epithelium-Derived Factor on Breast Cancer Cell versus Neuronal Survival: Implication for Brain Metastasis and Metastasis-Induced Brain Damage
Daniel P. Fitzgerald et al.
CANCER RESEARCH (2012)
Dual Inhibition of Plasminogen Kringle 5 on Angiogenesis and Chemotaxis Suppresses Tumor Metastasis by Targeting HIF-1α Pathway
Wei-Bin Cai et al.
PLOS ONE (2012)
Loss of pigment epithelium-derived factor: a novel mechanism for the development of endocrine resistance in breast cancer
Rifat Jan et al.
BREAST CANCER RESEARCH (2012)
The transcription factor ETS-1 regulates angiotensin II-stimulated fibronectin production in mesangial cells
Ping Hua et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Strategies to target molecules that control the acquisition of a mesenchymal-like phenotype by carcinoma cells
Claudia Palena et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2011)
Identification of a Novel Inhibitor of the Canonical Wnt Pathway
Kyoungmin Park et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
Ligand-independent activation of c-Met by fibronectin and α5β1-integrin regulates ovarian cancer invasion and metastasis
A. K. Mitra et al.
ONCOGENE (2011)
PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2-overexpressing breast cancer
V. Serra et al.
ONCOGENE (2011)
Culture of human breast cancer cell line (MDA-MB-231) on fibronectin-coated surface induces pro-matrix metalloproteinase-9 expression and activity
Gargi Maity et al.
TUMOR BIOLOGY (2011)
Breast cancer epithelial-to-mesenchymal transition: examining the functional consequences of plasticity
David J. Drasin et al.
BREAST CANCER RESEARCH (2011)
Plasma Fibronectin Promotes Lung Metastasis by Contributions to Fibrin Clots and Tumor Cell Invasion
Gunjan Malik et al.
CANCER RESEARCH (2010)
The Role of PEDF in Tumor Growth and Metastasis
D. Hoshina et al.
CURRENT MOLECULAR MEDICINE (2010)
被撤回的出版物: The Role of MAPK-ERK Pathway in 67-kDa Laminin Receptor-Induced FasL Expression in Human Cholangiocarcinoma Cells (Retracted article. See vol. 137, pg. 391, 2010)
Shi-Gang Duan et al.
DIGESTIVE DISEASES AND SCIENCES (2010)
Evaluation of protein pigment epithelium-derived factor (PEDF) and microvessel density (MVD) as prognostic indicators in breast cancer
Dan Zhou et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
The Fibrotic Phenotype Induced by IGFBP-5 Is Regulated by MAPK Activation and Egr-1-Dependent and -Independent Mechanisms
Hidekata Yasuoka et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
In vitro and in vivo biological activity of PEDF against a range of tumors
Matthew L. Broadhead et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2009)
Laminin Receptor Involvement in the Anti-angiogenic Activity of Pigment Epithelium-derived Factor
Adrien Bernard et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Characterization of PEDF: A Multi-Functional Serpin Family Protein
S. Filleur et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
'Loss of pigment epithelium-derived factor enables migration, invasion and metastatic spread of human melanoma'
J. L. Orgaz et al.
ONCOGENE (2009)
Rapid expression and activation of MMP-2 and MMP-9 upon exposure of human breast cancer cells (MCF-7) to fibronectin in serum free medium
Shamik Das et al.
LIFE SCIENCES (2008)
Pigment epithelium-derived factor overexpression inhibits orthotopic osteosarcoma growth, angiogenesis and metastasis
E. T. H. Ek et al.
CANCER GENE THERAPY (2007)
Inhibition of orthotopic osteosarcoma growth and metastasis by multitargeted antitumor activities of pigment epithelium-derived factor
Eugene T. H. Ek et al.
CLINICAL & EXPERIMENTAL METASTASIS (2007)
Identification of a lipase-linked cell membrane receptor for pigment epithelium-derived factor
Luigi Notari et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Cancer metastasis:: Building a framework
Gaorav P. Gupta et al.
CELL (2006)
PEDF: a potential molecular therapeutic target with multiple anti-cancer activities
Eugene T. H. Ek et al.
TRENDS IN MOLECULAR MEDICINE (2006)
Salutary effect of pigment epithelium-derived factor in diabetic nephropathy - Evidence for antifibrogenic activities
Joshua J. Wang et al.
DIABETES (2006)
Decreased pigment epithelium-derived factor expression in human breast cancer progression
Jun Cai et al.
CLINICAL CANCER RESEARCH (2006)
Complex networks orchestrate epithelial-mesenchymal transitions
JP Thiery et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Pigment epithelium-derived factor (PEDF)-induced apoptosis and inhibition of vascular endothelial growth factor (VEGF) expression in MG63 human osteosarcoma cells
K Takenaka et al.
LIFE SCIENCES (2005)
Breast cancer metastasis: Markers and models
B Weigelt et al.
NATURE REVIEWS CANCER (2005)
Pigment epithelium-derived factor is a substrate for matrix metalloproteinase type 2 and type 9:: Implications for downregulation in hypoxia
L Notari et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2005)
Inhibition of glioma invasion by overexpression of pigment epithelium-derived factor
M Guan et al.
CANCER GENE THERAPY (2004)
Overexpression of pigment epithelium-derived factor decreases angiogenesis and inhibits the growth of human malignant melanoma cells in vivo
R Abe et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Regulation of factors controlling angiogenesis in liver development: a role for PEDF in the formation and maintenance of normal vasculature
S Sawant et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Expression of pigment epithelium-derived factor decreases liver metastasis and correlates with favorable prognosis for patients with ductal pancreatic adenocarcinoma
H Uehara et al.
CANCER RESEARCH (2004)
Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progression
E Ioachim et al.
EUROPEAN JOURNAL OF CANCER (2002)
PEDF: anti-angiogenic guardian of ocular function
N Bouck
TRENDS IN MOLECULAR MEDICINE (2002)
Pigment epithelium-derived factor is elevated in CSF of patients with amyotrophic lateral sclerosis
RW Kuncl et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Share Paper
